H. Long

发表

Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells

K. Ladell, J. McLaren, E. James, 2019, The Journal of Immunology.

Cytotoxic Wave of Activated Antigen-Specific Primary EBV Infection Induces an Acute

K. Ladell, J. McLaren, E. James, 2019 .

Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children

S. Rowland-Jones, H. Whittle, A. Rickinson, 2015, PLoS pathogens.

Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory.

A. Rickinson, U. Palendira, C. Münz, 2014, Trends in immunology.

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.

W. Chan, C. Bollard, M. Rowe, 2010, Blood.

CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines

A. Rickinson, A. Leen, E. Houssaint, 2005, Journal of Virology.

A Role for Intercellular Antigen Transfer in the Recognition of EBV-Transformed B Cell Lines by EBV Nuclear Antigen-Specific CD4+ T Cells1

A. Rickinson, J. Brooks, G. Taylor, 2006, The Journal of Immunology.

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

M. Fitzpatrick, A. Rickinson, A. Leese, 2016, PLoS pathogens.

Potential for SARS-CoV-2 Virus Exposure During Gynaecological Procedures

G. Taylor, C. Shannon-Lowe, S. Sundar, 2020 .

Cytokine production and antigen recognition by human mucosal homing conjunctival effector memory CD8+ T cells.

S. Rauz, Geraint P Williams, S. Curnow, 2014, Investigative ophthalmology & visual science.

MHC II tetramers visualize human CD4+ T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response

A. Rickinson, E. James, W. Kwok, 2013, The Journal of experimental medicine.

T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display

A. Rickinson, J. Brooks, G. Taylor, 2009, PLoS pathogens.

CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.

A. Rickinson, A. Leese, G. Taylor, 2009, Blood.

University of Birmingham CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV- transformed lymphoblastoid cell lines

E. Houssaint, A. Rickinson, S. Lee, 2012 .

CD 4 + T-cell responses to Epstein-Barr virus ( EBV ) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines

A. Rickinson, A. Leen, E. Houssaint, 2012 .

A mutation in X‐linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein–Barr virus‐specific T cells

P. Klenerman, E. López-Granados, Anne-Kathrin Kienzler, 2014, Clinical and experimental immunology.

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

N. Croft, A. Purcell, G. Bendle, 2018, Journal of Immunotherapy for Cancer.

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases

P. Borrow, P. Moss, A. Rickinson, 2017, Journal of Virology.

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

G. Taylor, James E Turner, T. Haigh, 2021, PLoS pathogens.

Lines by EBV Nuclear Antigen-Specific CD4 the Recognition of EBV-Transformed B Cell A Role for Intercellular Antigen Transfer in

A. Rickinson, J. Brooks, G. Taylor, 2006 .

Regression of Epstein-Barr Virus-Induced B-Cell Transformation In Vitro Involves Virus-Specific CD8+ T Cells as the Principal Effectors and a Novel CD4+ T-Cell Reactivity

A. Rickinson, G. Taylor, T. Haigh, 2005, Journal of Virology.

Characterising EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.

C. Shannon-Lowe, P. Collins, C. Fox, 2020, Blood.

University of Birmingham Characterising EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Lowe, P. Collins, C. Fox, 2020 .

Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition

A. Rickinson, A. Leese, C. Shannon-Lowe, 2011, The Journal of Immunology.

The CD151midkine pathway regulates the immune microenvironment in inflammatory breast cancer

Giorgi, D. Rea, I. Nazarenko, 2020 .

Recruitment mechanisms of primary and malignant B cells to the human liver

P. Moss, C. Weston, G. Reynolds, 2012, Hepatology.

Cycle Recognition Lytic Cycle Antigen Choice and in Lytic Contrast with CD8 Responses in Breadth of T Cell Responses to EBV + Cytotoxic CD4

A. Rickinson, A. Leese, C. Shannon-Lowe, 2011 .

Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2

M. Rowe, A. Hislop, G. Taylor, 2011, PLoS pathogens.

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

Amit A. Patel, F. Ginhoux, D. Busch, 2021, European journal of immunology.

Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200

Janet M. Lord, J. Lord, O. Goodyear, 2012, Journal of Virology.

Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression and Function of Endothelial Cell Major Histocompatibility Complex Class II via Suppressor of Cytokine Signaling 3

G. Nash, D. Blackbourn, L. Butler, 2012, Journal of Virology.

CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles

Di Wu, Di Yu, Peng Wang, 2016, Nature Immunology.

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

Andrew I. Bell, Josef Mautner, Georg W. Bornkamm, 2009, PLoS pathogens.

The immunology of Epstein-Barr virus-induced disease.

A. Rickinson, A. Hislop, J. Brooks, 2015, Annual review of immunology.

BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.

A. Strasser, O. Kondrashova, G. Lessene, 2020, Blood advances.

Immune defence against EBV and EBV-associated disease.

A. Rickinson, G. Taylor, H. Long, 2011, Current opinion in immunology.

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.

C. Shannon-Lowe, P. Collins, C. Fox, 2021, Blood.

Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition.

G. Taylor, T. Haigh, H. Parry, 2022, Nature immunology.

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

S. Ladhani, K. Hoschler, K. Brown, 2020, bioRxiv.

Programmed Necrosis in the Cross Talk of Cell Death and Inflammation

C. Hunter, A. Rickinson, A. Hislop, 2016 .

EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses1

M. Bonneville, E. Houssaint, G. Taylor, 2006, The Journal of Immunology.

The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog

G. Taylor, Benjamin J Meckiff, H. Long, 2019, Front. Immunol..

EBV-Specific CD 4 T Cell Clones Exhibit Vigorous Allogeneic Responses 1

M. Bonneville, E. Houssaint, G. Taylor, 2006 .

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

N. Russell, P. Murray, E. Nagy, 2019, Front. Immunol..

Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery

Benjamin J Meckiff, M. Bishton, C. Fox, 2019, Leukemia & lymphoma.

The CD151‐midkine pathway regulates the immune microenvironment in inflammatory breast cancer

D. Rea, S. V. van Laere, I. Nazarenko, 2020, The Journal of pathology.

Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia

T. Stankovic, P. Moss, G. Pratt, 2019, Front. Immunol..

Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner.

S. Hayward, V. Speirs, S. V. van Laere, 2023, Cell reports.

Immunotherapy for Epstein-Barr virus-associated malignancies.

Steven P Lee, C. Fox, H. Long, 2010, Drug news & perspectives.

Tracking immunodynamics by identification of S-G2/M-phase T cells in human peripheral blood☆☆☆

A. Hayday, M. Peakman, M. Greco, 2020, Journal of autoimmunity.

Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity

A. Sewell, P. Rizkallah, A. Greenshields-Watson, 2023, Cell reports.

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

S. Ladhani, K. Hoschler, K. Brown, 2021, Nature Immunology.

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

Amit A. Patel, F. Ginhoux, D. Busch, 2021, European journal of immunology.

University of Birmingham Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery

Benjamin J Meckiff, M. Bishton, H. Long, 2019 .

Targeting EBV-positive B- and T/NK-cell lymphomas.

H. Long, 2018, Blood.